20 Dec Effective Market Exclusivity of New Molecular Entities for Rare and Non-rare Diseases
Kirk Kerr and Lukas Glos, economist at the Center for Drug Evaluation and Research, U.S. Food and Drug Administration, are publishing in Pharmaceutical Medicine, an article on Effective Market...